Navigation Links
ClearCanvas Releases First Commercial Version of Widely Used PACS; Integrated RIS/PACS to Follow
Date:5/31/2011

TORONTO, May 31, 2011 /PRNewswire/ -- ClearCanvas Inc., an innovative medical imaging informatics company, today announced the commercial release of their radiology PACS offering, ClearCanvas PACS, Team Edition. Following the April release of their first commercial radiology workstation product, this PACS release signifies the first commercial version of their widely accepted DICOM ImageServer software, previously only offered as an open source application.

With the release of the PACS, Team Edition, small radiology practices now have access to a robust FDA cleared ClearCanvas product suite designed with them in mind.  Building on the open source ImageServer, the Team Edition includes a concurrent workstation licensing model, unlimited web-based image viewing, roaming user profiles, JPEG2000 compression support, and centralized audit logs. In addition, the Team Edition workstation includes all of the same features as the Clinical Edition, including Media Writing, DICOM Print, and PET/CT Fusion.

The ClearCanvas PACS, Team Edition is available for purchase through a small but rapidly growing number of resellers worldwide.

"My vision for ClearCanvas has always been to offer integrated workflow solutions to the medical imaging community - and not just image viewing applications," says Norman Young, CEO. "With features like roaming user profiles and web-based access to images, the Team Edition represents the next step in that direction. We are very excited about how the Team Edition will empower small radiology practices all over the world."

ClearCanvas expects a commercial release of their integrated RIS/PACS in early 2012. Additional versions of both the Workstation and the PACS are already planned for 2011; product upgrades and technical support are included free of charge during the first license year. ClearCanvas will continue to release new versions of their open source software as well.

ClearCanvas Inc. develops innovative and easy-to-use medical imaging informatics software, including clinical workstations, PACS, and RIS. ClearCanvas products are used worldwide by more than 15,000 clinicians, researchers, and developers. Their open source applications are freely available and their commercial applications deliver good value at a fair price. To learn more, visit http://www.clearcanvas.ca.

Contact:

Mary Burrell
Director, Technical Sales & Marketing
+1.970.372.6631
mary@clearcanvas.ca

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE ClearCanvas Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
2. Aureus Pharma Releases AurPROFILER(R) - a New and Powerful Pharmacology Profiling Solution
3. Aureus Pharma Releases New Unified Knowledge Database
4. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
5. Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
6. Presidio Pay Advisors Releases Salary GPS Tool
7. Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
8. BioWisdom Releases Text Analytics Version of OmniViz for Patent Specialists
9. T-System Releases The T SystemEV(R) 2.6.3, Featuring New Meds/Allergies Notification, Automated Charge Capture
10. BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
11. Sigma-Aldrich Releases WTA2, a Transplex Whole Transcriptome Amplification Technology for Degraded RNA Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):